<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore the relationship between <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: The Fremantle <z:mp ids='MP_0002055'>Diabetes</z:mp> Study (FDS) was a community-based longitudinal observational study of 1426 subjects, 1294 of which had type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The FDS type 2 cohort and four age-, sex- and postcode-matched controls per case were followed for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> events from 1993 until mid-2010 and incidence rate ratios (IRRs) were calculated </plain></SENT>
<SENT sid="3" pm="."><plain>Competing risks proportional hazards models generated risk factors for incident <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in the diabetic group </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: There were 309 first <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> over 13 051 patient-years, or 2368 (95% confidence interval (95% CI) 2111-2647)/100 000 patient-years in the <z:mp ids='MP_0002055'>diabetes</z:mp> patients vs 1131 over 60 324 patient-years (1875 (1769-1987)/100 000 patient-years) in the controls </plain></SENT>
<SENT sid="5" pm="."><plain>For those aged ≥45 years, the risk of <z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was elevated in type 2 diabetic men (IRRs 1.23, 95% CI 1.04-1.45) and women (1.30, 1.06-1.59) </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was increased (1.36, 1.01-1.82), especially in diabetic men aged 75-84 years (2.14, 1.22-3.64) </plain></SENT>
<SENT sid="7" pm="."><plain>Age at <z:mp ids='MP_0002055'>diabetes</z:mp> diagnosis (sub-hazard ratio 1.05, 1.02-1.09), <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi> therapy (2.37, 1.39-4.06), recent exercise (2.11, 1.06-4.20) and serum total cholesterol (0.68, 0.52-0.88) increased <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002894'>Pancreatic cancer</z:hpo> was also more frequent in the diabetic patients (IRR 2.26, 1.20-4.10) </plain></SENT>
<SENT sid="9" pm="."><plain>Diabetic men and women had similar risks of prostate and <z:hpo ids='HP_0003002'>breast cancer</z:hpo> to those of controls (0.83, 0.59-1.14 and 0.86, 0.52-1.36) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with a moderately increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in well-characterised community-based patients, especially <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in older men </plain></SENT>
<SENT sid="11" pm="."><plain>Recommended <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> screening should be considered as part of routine <z:mp ids='MP_0002055'>diabetes</z:mp> management </plain></SENT>
</text></document>